[PHARMA] YoY Annualized Quarter Result on 30-Jun-2012 [#2]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
08-Aug-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Jun-2012 [#2]
Profit Trend
QoQ- -22.61%
YoY- 50.99%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Revenue 1,969,498 1,987,488 1,875,944 1,806,964 1,563,526 1,335,790 1,293,856 7.25%
PBT 127,336 125,562 93,058 141,146 82,344 65,516 89,042 6.14%
Tax -30,200 -40,356 -30,410 -50,870 -23,056 -17,862 -22,610 4.94%
NP 97,136 85,206 62,648 90,276 59,288 47,654 66,432 6.53%
-
NP to SH 96,022 84,384 61,272 88,796 58,808 48,108 64,438 6.87%
-
Tax Rate 23.72% 32.14% 32.68% 36.04% 28.00% 27.26% 25.39% -
Total Cost 1,872,362 1,902,282 1,813,296 1,716,688 1,504,238 1,288,136 1,227,424 7.28%
-
Net Worth 527,991 502,162 481,681 481,282 451,381 417,306 400,063 4.73%
Dividend
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Div 72,469 41,415 35,323 35,301 - 100,581 57,763 3.85%
Div Payout % 75.47% 49.08% 57.65% 39.76% - 209.07% 89.64% -
Equity
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Net Worth 527,991 502,162 481,681 481,282 451,381 417,306 400,063 4.73%
NOSH 258,819 258,846 258,968 117,672 106,962 107,001 106,968 15.85%
Ratio Analysis
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
NP Margin 4.93% 4.29% 3.34% 5.00% 3.79% 3.57% 5.13% -
ROE 18.19% 16.80% 12.72% 18.45% 13.03% 11.53% 16.11% -
Per Share
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 760.95 767.82 724.39 1,535.58 1,461.75 1,248.38 1,209.56 -7.43%
EPS 37.10 32.60 23.66 75.46 54.98 44.96 60.24 -7.75%
DPS 28.00 16.00 13.64 30.00 0.00 94.00 54.00 -10.36%
NAPS 2.04 1.94 1.86 4.09 4.22 3.90 3.74 -9.60%
Adjusted Per Share Value based on latest NOSH - 117,700
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
RPS 136.65 137.90 130.16 125.37 108.48 92.68 89.77 7.25%
EPS 6.66 5.85 4.25 6.16 4.08 3.34 4.47 6.86%
DPS 5.03 2.87 2.45 2.45 0.00 6.98 4.01 3.84%
NAPS 0.3663 0.3484 0.3342 0.3339 0.3132 0.2895 0.2776 4.72%
Price Multiplier on Financial Quarter End Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 30/06/10 30/06/09 -
Price 7.13 4.61 4.49 10.18 5.90 4.98 3.80 -
P/RPS 0.94 0.60 0.62 0.66 0.40 0.40 0.31 20.29%
P/EPS 19.22 14.14 18.98 13.49 10.73 11.08 6.31 20.38%
EY 5.20 7.07 5.27 7.41 9.32 9.03 15.85 -16.94%
DY 3.93 3.47 3.04 2.95 0.00 18.88 14.21 -19.27%
P/NAPS 3.50 2.38 2.41 2.49 1.40 1.28 1.02 22.80%
Price Multiplier on Announcement Date
30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 30/06/10 30/06/09 CAGR
Date 17/08/15 21/08/14 16/08/13 08/08/12 10/08/11 11/08/10 21/08/09 -
Price 5.65 4.62 4.66 8.83 5.90 4.95 4.00 -
P/RPS 0.74 0.60 0.64 0.58 0.40 0.40 0.33 14.40%
P/EPS 15.23 14.17 19.70 11.70 10.73 11.01 6.64 14.83%
EY 6.57 7.06 5.08 8.55 9.32 9.08 15.06 -12.90%
DY 4.96 3.46 2.93 3.40 0.00 18.99 13.50 -15.36%
P/NAPS 2.77 2.38 2.51 2.16 1.40 1.27 1.07 17.17%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment